FDA Shows Skin Authority Who’s Boss With Warning For Drug Claims
This article was originally published in The Rose Sheet
Yet another skin-care marketer, Skin Authority, has been served with an FDA warning letter for excessive product claims that identify its offerings as drugs. The agency cites statements touting the firm’s ingredient benefits, including collagen production, improved circulation, inflammation relief and hyperpigmentation treatment, consistent with other warnings issued to cosmetics firms in recent months.
You may also be interested in...
A key component of FDA’s enforcement strategy in the cosmetics space is monitoring companies’ websites for overreaching product claims and issuing warning letters accordingly. Examination of past offenders’ current sites and updated claims offers potential visibility into language the agency will and will not tolerate when it comes to promoting skin-care benefits.
A growing number of injectable skin-whitening products are available to consumers through online retailers and other channels, FDA says in an update cautioning the public that such products could pose "significant" safety risks. The agency singles out Flawless Beauty, LLC, which has been subject to recent enforcement activity, including product seizure by U.S. Marshals, but continues to market questionable skin-whitening products with aggressive claims.
NuGene's sales have soared with expanded distribution, but increased regulation continues to be a risk to its human stem-cell-based cosmeceuticals business, the firm notes. Skin and hair-care line extensions will launch later this year, and the company is considering developing an in-house sales force.